Inventor
RAMAKRISHNAN VANITHA
US20 patents
⚠️ This page may combine multiple inventors who share the name “RAMAKRISHNAN VANITHA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
FACET BIOTECH CORP
6 patentsUS7662384B2Feb 16, 2010
Use of anti-α5β1 antibodies to inhibit cancer cell proliferation
FACET BIOTECH CORP21 citations89
US7824678B2Nov 2, 2010
Antibodies against cancer antigen TMEFF2 and uses thereof
FACET BIOTECH CORP4 citations72
US7674883B2Mar 9, 2010
Antibodies against cancer antigen TMEFF2 and uses thereof
FACET BIOTECH CORP6 citations72
US7785816B2Aug 31, 2010
Antibodies against cancer antigen TMEFF2 and uses thereof
FACET BIOTECH CORP2 citations61
US7879987B2Feb 1, 2011
Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis
FACET BIOTECH CORP0 citations51
US7776585B2Aug 17, 2010
Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis
FACET BIOTECH CORP0 citations51
PDL BIOPHARMA INC
4 patentsUS7399469B2Jul 15, 2008
Anti-LFL2 antibodies for the diagnosis, prognosis and treatment of cancer
PDL BIOPHARMA INC22 citations92
US7288248B2Oct 30, 2007
Antibodies against cancer antigen TMEFF2 and uses thereof
PDL BIOPHARMA INC27 citations91
US7285268B2Oct 23, 2007
Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis
PDL BIOPHARMA INC18 citations91
US7276589B2Oct 2, 2007
Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis
PDL BIOPHARMA INC23 citations91
HARPOON THERAPEUTICS INC
3 patentsUS9708412B2Jul 18, 2017
Trispecific binding proteins and methods of use
HARPOON THERAPEUTICS INC66 citations97
US10954311B2Mar 23, 2021
Trispecific binding proteins and methods of use
HARPOON THERAPEUTICS INC9 citations85
US12084518B2Sep 10, 2024
Trispecific binding proteins and methods of use
HARPOON THERAPEUTICS INC0 citations62